All Things Newz
Law \ Legal

Updates To Health Canada’s Regulatory Initiatives For 2022-2024, And Amendments To Food And Drug Regulations (Exports And Transhipments Of Drugs) – Healthcare



To print this article, all you need is to be registered or login on Mondaq.com.

Health Canada has updated its Forward
Regulatory Plan: 2022-2024
, providing information on regulatory
initiatives Health Canada aims to propose or finalize over the next
two years. Some of the new and updated initiatives pertaining to
the Food and Drugs Act are highlighted below:

New initiatives:

Updated initiatives:

Health Canada has also updated its Regulatory Stock Review Plan: 2022-2024,
which is a public list and description of planned reviews of
regulations that Health Canada is proposing within a two-year
period. The Stock Review Plan overlaps with some of the above
described initiatives.

Should you have any questions, please do not hesitate to contact
a member of the Life Sciences Regulatory
& Compliance
group.

The preceding is intended as a timely update on Canadian
intellectual property and technology law. The content is
informational only and does not constitute legal or professional
advice. To obtain such advice, please communicate with our offices
directly.

POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from Canada



Source link

Related posts

Embracing inclusive design beyond the legal minimum: A case for making Australia more accessible for all – Construction & Planning

Moving To Portugal – Tax Planning And The Non-Habitual Resident Regime – Capital Gains Tax

Noisy Neighbour? You May Not Be Entitled To A Legal Remedy – Trials & Appeals & Compensation